132 related articles for article (PubMed ID: 2391063)
1. Fine specificity of human antibody response to the PreS1 domain of hepatitis B virus.
Alberti A; Cavalletto D; Chemello L; Belussi F; Fattovich G; Pontisso P; Milanesi G; Ruol A
Hepatology; 1990 Aug; 12(2):199-203. PubMed ID: 2391063
[TBL] [Abstract][Full Text] [Related]
2. Variable expression of preS1 antigen in serum during chronic hepatitis B virus infection: an accurate marker for the level of hepatitis B virus replication.
Petit MA; Zoulim F; Capel F; Dubanchet S; Dauguet C; Trepo C
Hepatology; 1990 May; 11(5):809-14. PubMed ID: 2347555
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective.
Neurath AR; Seto B; Strick N
Vaccine; 1989 Jun; 7(3):234-6. PubMed ID: 2476893
[TBL] [Abstract][Full Text] [Related]
4. A monoclonal antibody specific to the non-epitope region of hepatitis B virus preS1 contributes to more effective HBV detection.
Zhang Z; Li X; Yi W; Li S; Hu C; Chen A
Clin Biochem; 2013 Aug; 46(12):1105-1110. PubMed ID: 23608352
[TBL] [Abstract][Full Text] [Related]
5. N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus.
Bremer CM; Sominskaya I; Skrastina D; Pumpens P; El Wahed AA; Beutling U; Frank R; Fritz HJ; Hunsmann G; Gerlich WH; Glebe D
J Hepatol; 2011 Jul; 55(1):29-37. PubMed ID: 21145866
[TBL] [Abstract][Full Text] [Related]
6. Expression and immunoactivity of chimeric particulate antigens of receptor binding site-core antigen of hepatitis B virus.
Yang HJ; Chen M; Cheng T; He SZ; Li SW; Guan BQ; Zhu ZH; Gu Y; Zhang J; Xia NS
World J Gastroenterol; 2005 Jan; 11(4):492-7. PubMed ID: 15641132
[TBL] [Abstract][Full Text] [Related]
7. Fine mapping of virus-neutralizing epitopes on hepatitis B virus PreS1.
Maeng CY; Ryu CJ; Gripon P; Guguen-Guillouzo C; Hong HJ
Virology; 2000 Apr; 270(1):9-16. PubMed ID: 10772975
[TBL] [Abstract][Full Text] [Related]
8. Assay of preS epitopes and preS1 antibody in hepatitis B virus carriers and immune persons.
Deepen R; Heermann KH; Uy A; Thomssen R; Gerlich WH
Med Microbiol Immunol; 1990; 179(1):49-60. PubMed ID: 1691815
[TBL] [Abstract][Full Text] [Related]
9. A monoclonal antibody specific for the hepatocyte receptor binding site on hepatitis B virus.
Petit MA; Dubanchet S; Capel F
Mol Immunol; 1989 Jun; 26(6):531-7. PubMed ID: 2475766
[TBL] [Abstract][Full Text] [Related]
10. Detection of anti-preS1 antibodies for recovery of hepatitis B patients by immunoassay.
Wei J; Wang YQ; Lu ZM; Li GD; Wang Y; Zhang ZC
World J Gastroenterol; 2002 Apr; 8(2):276-81. PubMed ID: 11925607
[TBL] [Abstract][Full Text] [Related]
11. Correlation of preS antigens and clinical status during chronic hepatitis B virus infection.
Taliani G; Rapicetta M; Francisci D; Xiang J; Sarrecchia B; De Bac C; Stagni G
Med Microbiol Immunol; 1991; 180(5):239-48. PubMed ID: 1762604
[TBL] [Abstract][Full Text] [Related]
12. HepG2 cell binding activities of different hepatitis B virus isolates: inhibitory effect of anti-HBs and anti-preS1(21-47).
Petit MA; Dubanchet S; Capel F; Voet P; Dauguet C; Hauser P
Virology; 1991 Feb; 180(2):483-91. PubMed ID: 1703368
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B.
Kohno H; Inoue T; Tsuda F; Okamoto H; Akahane Y
J Gen Virol; 1996 Aug; 77 ( Pt 8)():1825-31. PubMed ID: 8760433
[TBL] [Abstract][Full Text] [Related]
14. Construction and Characterization of an Anti-Hepatitis B Virus preS1 Humanized Antibody that Binds to the Essential Receptor Binding Site.
Wi J; Jeong MS; Hong HJ
J Microbiol Biotechnol; 2017 Jul; 27(7):1336-1344. PubMed ID: 28478661
[TBL] [Abstract][Full Text] [Related]
15. Primary cultured normal human hepatocytes for hepatitis B virus receptor studies.
Mabit H; Vons C; Dubanchet S; Capel F; Franco D; Petit MA
J Hepatol; 1996 Apr; 24(4):403-12. PubMed ID: 8738726
[TBL] [Abstract][Full Text] [Related]
16. Detection of hepatitis B virus PreS1 antigen using a time-resolved fluoroimmunoassay.
Hu Z; Li M; Huang B; Liu J; Yu L; Chen G
J Immunoassay Immunochem; 2012; 33(2):156-65. PubMed ID: 22471606
[TBL] [Abstract][Full Text] [Related]
17. Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes.
Glebe D; Urban S; Knoop EV; Cag N; Krass P; Grün S; Bulavaite A; Sasnauskas K; Gerlich WH
Gastroenterology; 2005 Jul; 129(1):234-45. PubMed ID: 16012950
[TBL] [Abstract][Full Text] [Related]
18. Properties of modified hepatitis B virus surface antigen particles carrying preS epitopes.
Prange R; Werr M; Birkner M; Hilfrich R; Streeck RE
J Gen Virol; 1995 Sep; 76 ( Pt 9)():2131-40. PubMed ID: 7561750
[TBL] [Abstract][Full Text] [Related]
19. Generation and Characterization of a Neutralizing Human Monoclonal Antibody to Hepatitis B Virus PreS1 from a Phage-Displayed Human Synthetic Fab Library.
Jo G; Jeong MS; Wi J; Kim DH; Kim S; Kim D; Yoon JY; Chae H; Kim KH; Hong HJ
J Microbiol Biotechnol; 2018 Aug; 28(8):1376-1383. PubMed ID: 30301315
[TBL] [Abstract][Full Text] [Related]
20. The clinical and epidemiological significance of serum PreS1/anti-PreS1 in HBV infection.
Mi Z; Feng F; Zhang X; Lian Z; Wang H; Tong Y
Chin Med J (Engl); 1999 Apr; 112(4):321-4. PubMed ID: 11593530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
